Predicting the future of autoimmune encephalitides

2024-9-1

What's new in NMOSD and MOGAD?

2024-9-1

Impact of physical activity, physical fitness and exercises on cognitive impairment in patients with multiple sclerosis: A review of evidence and underlying mechanisms

2024-9-1

Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors

2024-9-1

Contents

2024-9-1

Neurofilament-light: Impact of chronic stress on brain

2024-9-1

Innovative minimally invasive options to treat drug-resistant epilepsies

2024-9-1

Editorial Board

2024-8-22

Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review

2024-8-1

The role of SEEG in the presurgical decision-making process in MRI-normal mesial temporal lobe epilepsy

2024-8-1

Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations

2024-7-1

Mothership versus Drip-and-Ship for stroke in a rural area: A French prospective observational study

2024-7-1

Poststroke cognitive outcome is better accounted for by white matter abnormalities automated segmentation than visual analysis

2024-7-1

French consensus procedure for neuropsychological assessment in multiple sclerosis

2024-7-1

Contents

2024-6-1

Between neurology and psychiatry: The lively history of right hemisphere syndromes

2024-6-1

In young patients with stroke of undetermined etiology, large vessel occlusions are less frequent in the group with high-risk patent foramen ovale

2024-6-1

Synapse and primary cilia dysfunctions in Autism Spectrum Disorders. Avenues to normalize these functions

2024-6-1

Herpes simplex virus-2 meningo-encephalitis hiding a criminal case of fatal methylmercury poisoning

2024-6-1

Neuropsychological assessment in pediatric epilepsy surgery: A French procedure consensus

2024-6-1

Cortical type memory impairment in CADASIL: Watch out for the second train!

2024-6-1

SWI versus GRE-T2*: Assessing cortical superficial siderosis in advanced cerebral amyloid angiopathy

2024-6-1

Tribute to Maurice Collard (1931–2024)

2024-6-1

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort

2024-6-1

Remote neurological evaluation reliably identifies patients eligible to endovascular therapy while non-eligible to intravenous thrombolysis

2024-6-1

Editorial Board

2024-6-1

Seizure recurrences in generalized convulsive status epilepticus under sedation: What are its predictors and its impact on outcome?

2024-6-1

Model-based cueing-as-needed for walking in Parkinson's disease: A randomized cross-over study

2024-6-1

Limb-girdle muscle weakness and muscle hypertrophy: Do not dismiss spinal muscular atrophy

2024-6-1

Silent brain infarct in migraine: Systematic review and meta-analysis

2024-6-1

Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease

2024-6-1

Evaluation of quality of life's prognostic factors in people with functional seizures

2024-6-1

Outcome of stroke patients eligible to mechanical thrombectomy managed by spoke center, primary stroke center or comprehensive stroke center in the East of France

2024-6-1

Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy

2024-6-1

Marian apparitions: A multidisciplinary approach. The case of Île Bouchard

2024-5-1

Metabolic syndrome and the phenotype of multiple sclerosis

2024-5-1

Self-reported outcomes and quality of life of patients with non-dystrophic myotonia: The French IMPACT 2022 survey

2024-5-1

Clinical applications of deep learning in neuroinflammatory diseases: A scoping review

2024-5-1

Directional deep brain stimulation is useful to correct the misplacement of intracerebral electrode after reimplantation

2024-5-1

Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia

2024-5-1

Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3

2024-5-1

Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data

2024-5-1

The “zebra sign” after a lumbar puncture

2024-5-1

French guidelines for the diagnosis and management of Tourette syndrome

2024-5-1

Vanishing white matter in multiple mitochondrial dysfunction syndrome-2 due to compound heterozygosity for novel BOLA3 variants

2024-5-1

Association of clopidogrel resistance and ABCD-GENE score with long-term clinical prognosis in patients with ischemic stroke or TIA

2024-5-1

Editorial Board

2024-5-1

Contents

2024-5-1

Updates in neurogenetics

2024-5-1

Diagnosis and management of acute trigeminal neuralgia

2024-5-1